SCP-2837
Safe
~
medium confidence
SCP-2837
Expected annual
$6.6M
One-time setup
$35.1M
Annual recurring
$6.5M
Personnel
41
One-time capital and contingency requirements total approximately $35.1M, driven primarily by program-level catastrophic reserve, site-specific construction and major instrumentation. Annual recurring costs are roughly $6.47M/yr, driven by staff wages (security and research), ongoing research operations, and maintenance/contingency reserves.
One-Time Capital Costs
Total: $35.1M
Annual Recurring Costs
Total: $6.5M/yr
Cost Scenarios
📊
Baseline
(baseline)
$6.5M/yr
Normal operational year with no major incidents; routine research, maintenance, and staffing costs only.
routine operations
scheduled experiments
no containment incidents
🚨
Minor Incident
$7.2M/yr
Localized equipment failure, small contamination event, or a short-notice replacement/repair requiring emergency purchases and short quarantines.
robot/equipment failure
localized thermal/particle event
small contamination requiring replacement
🚨
Catastrophic Combined Instances
$56.5M/yr
Accidental co-location/transport error leading to combined-instance effects, wide-area biological decay requiring demolition, remediation, and long-term monitoring.
accidental co-location during transport
major containment breach with environmental remediation
Personnel
41 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 27 | [#13] Incremental 24/7 security coverage calculated from the allocated security staffing budget (approx. $1.6M/yr at ~$60k loaded per FTE). |
| Research Scientist | 4 | [#14] Lead researchers (one per site) funded within the scientific staffing line. |
| Lab Technician | 8 | [#14] Technicians for telepresence operations and experiment support (two per site). |
| Program Manager / Executive Staff | 2 | [#29] Program-level coordination and oversight staff funded within program management. |
Confidence Notes
Analyst notes provide detailed line-item ranges and explicit recommended estimates for many categories, enabling a reasonable mid-confidence estimate; however, significant uncertainties remain due to anomalous particle interactions, R&D escalation risk, and the subjective choice of point estimates within broad ranges.